These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6329760)

  • 1. Prognostic parameters in patients with advanced ovarian malignant tumors.
    Pohl R; Dallenbach-Hellweg G; Plügge T; Czernobilsky B
    Eur J Gynaecol Oncol; 1984; 5(3):160-9. PubMed ID: 6329760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of histologic classification and grading of epithelial malignancies of the ovary.
    Malkasian GD; Melton LJ; O'Brien PC; Greene MH
    Am J Obstet Gynecol; 1984 Jun; 149(3):274-84. PubMed ID: 6328995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical differentiation between ovarian granulosa cell tumors and ovarian carcinomas.
    Gitsch G; Kohlberger P; Hanzal E; Kölbl H; Breitenecker G
    Arch Gynecol Obstet; 1991; 249(4):173-7. PubMed ID: 1665684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
    Sherman ME; Mink PJ; Curtis R; Cote TR; Brooks S; Hartge P; Devesa S
    Cancer; 2004 Mar; 100(5):1045-52. PubMed ID: 14983501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing survival in carcinoma of the ovary.
    Dyson JL; Beilby JO; Steele SJ
    Br J Cancer; 1971 Jun; 25(2):237-49. PubMed ID: 4329950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucinous tumors of the ovary: a clinicopathologic analysis of 75 borderline tumors (of intestinal type) and carcinomas.
    Rodríguez IM; Prat J
    Am J Surg Pathol; 2002 Feb; 26(2):139-52. PubMed ID: 11812936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of borderline ovarian tumors.
    Harlow BL; Weiss NS; Lofton S
    J Natl Cancer Inst; 1987 Jan; 78(1):71-4. PubMed ID: 3025504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and treatment outcomes of patients with malignant transformation arising from mature cystic teratoma of the ovary: experience at a single institution.
    Oranratanaphan S; Khemapech N
    Asian Pac J Cancer Prev; 2013; 14(8):4693-7. PubMed ID: 24083728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should All Cases of High-Grade Serous Ovarian, Tubal, and Primary Peritoneal Carcinomas Be Reclassified as Tubo-Ovarian Serous Carcinoma?
    Moss EL; Evans T; Pearmain P; Askew S; Singh K; Chan KK; Ganesan R; Hirschowitz L
    Int J Gynecol Cancer; 2015 Sep; 25(7):1201-7. PubMed ID: 26035124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic and nuclear grading and stromal reactions as indices for prognosis in ovarian cancer.
    Barber HR; Sommers SC; Synder R; Kwon TH
    Am J Obstet Gynecol; 1975 Mar; 121(6):795-807. PubMed ID: 1092171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of lymph node staging method and prognostic factors in malignant ovarian sex cord-stromal tumors: A world wide database analysis.
    Wang J; Li J; Chen R; Lu X
    Eur J Surg Oncol; 2018 Jul; 44(7):1054-1061. PubMed ID: 29705285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between residual disease and survival in epithelial ovarian cancer by histologic type.
    Melamed A; Manning-Geist B; Bregar AJ; Diver EJ; Goodman A; Del Carmen MG; Schorge JO; Rauh-Hain JA
    Gynecol Oncol; 2017 Nov; 147(2):250-256. PubMed ID: 28822556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of lymphadenectomy and prevalence of lymph node metastasis in clinically-apparent stage I endometrioid and mucinous ovarian carcinoma.
    Nasioudis D; Chapman-Davis E; Witkin SS; Holcomb K
    Gynecol Oncol; 2017 Feb; 144(2):414-419. PubMed ID: 27908528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of Patients With Mucinous Ovarian Carcinoma and Ovarian Metastases: A Population-Based Cancer Registry Study.
    Simons M; Ezendam N; Bulten J; Nagtegaal I; Massuger L
    Int J Gynecol Cancer; 2015 Sep; 25(7):1208-15. PubMed ID: 25978291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical characteristics and prognosis of epithelial ovarian cancer in young women].
    Tang L; Zheng M; Xiong Y; Ding H; Liu FY
    Ai Zheng; 2008 Sep; 27(9):951-5. PubMed ID: 18799034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant and borderline epithelial ovarian tumors in the pediatric and adolescent population.
    Nasioudis D; Alevizakos M; Holcomb K; Witkin SS
    Maturitas; 2017 Feb; 96():45-50. PubMed ID: 28041594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in ovarian cancer.
    Rakar S; Kovacic J; Cavic M; Lukanovic A; Mozina A
    Eur J Gynaecol Oncol; 1990; 11(3):171-3. PubMed ID: 2170137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunohistochemical differentiation of granulosa cell tumors and undifferentiated ovarian cancers].
    Kohlberger P
    Wien Klin Wochenschr; 1993; 105(20):589-90. PubMed ID: 8259687
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term prognosis of stage I ovarian carcinoma. Prognostic importance of intraoperative rupture.
    Mizuno M; Kikkawa F; Shibata K; Kajiyama H; Suzuki T; Ino K; Kawai M; Mizutani S
    Oncology; 2003; 65(1):29-36. PubMed ID: 12837980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the histogenesis and morphology of ovarian carcinomas.
    Dallenbach-Hellweg G
    J Cancer Res Clin Oncol; 1984; 107(2):71-80. PubMed ID: 6715398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.